NANO MRNA Co., Ltd.
4571・Growth Market・Pharmaceuticals
Governance
Company with a Board of Corporate Auditors. The Board of Directors consists of 8 members (2 of whom are outside directors, a 25% outside ratio), and the Board of Corporate Auditors consists of 3 members (all outside). A voluntary compensation committee has been established to enhance independence and objectivity. No nomination committee has been established.
Risk Management
A risk control matrix is prepared under the internal control system, which is checked quarterly by the Internal Audit Office. A Compliance Committee has been established as an advisory body to the Board of Directors, and a system for prompt information gathering and command in the event of a risk occurrence has been put in place.
Shareholder Returns
No dividend continues for FY2026 (ending March 2026) (annual dividend ¥0). The forecast for FY2027 (ending March 2027) is also no dividend. Due to continued recording of net losses, the company prioritizes securing funds for R&D and investment activities, and will consider its dividend policy once profitability is achieved. No share buybacks have been conducted.
Dividend Policy
The annual dividend for FY2026 (ending March 2026) is ¥0 (no dividend). The forecast for FY2027 (ending March 2027) is also ¥0. Since its founding, the company has recorded net losses attributable to owners of the parent and has not paid any dividends. The policy is to prioritize securing funds in preparation for the continued implementation of R&D activities and investment operations. Once profits are recorded, the company will consider its dividend policy taking into account its business performance and financial position. If dividends are paid, a single year-end dividend per year is envisioned.
ESG
The company focuses on resolving social issues through investment in the drug discovery and healthcare fields, investing in human capital (targeting maintenance of a 37.5% ratio of female managers), and reducing environmental impact through energy conservation and waste reduction, and manages sustainability-related risks quarterly using a risk control table.
Last updated: June 26, 2026